Genprex Inc

NASDAQ:GNPX   4:00:00 PM EDT
2.12
-0.09 (-4.07%)
7:29:36 PM EDT: $2.12 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Genprex Inc Stock, NASDAQ:GNPX

3300 Bee Cave Road, Suite 650-227, Austin, Texas 78746
United States of America
Phone: +1.877.774.4679
Number of Employees: 26
http://www.genprex.com

Description

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company�s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.